Impact of Polymer Formulations on Neointimal Proliferation After Zotarolimus-Eluting Stent With Different Polymers | Zendy

Katsuhisa Waseda | Zendy; Junya Ako | Zendy; Masao Yamasaki | Zendy; Tomomi Koizumi | Zendy; Ryota Sakurai | Zendy; Yoichiro Hongo | Zendy; BonKwon Koo | Zendy; John A. Ormiston | Zendy; Stephen G. Worthley | Zendy; Robert Whitbourn | Zendy; D. Walters | Zendy; Ian T. Meredith | Zendy; Peter J. Fitzgerald | Zendy; Yasuhiro Honda | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Impact of Polymer Formulations on Neointimal Proliferation After Zotarolimus-Eluting Stent With Different Polymers

Author(s) -

Katsuhisa Waseda,

Junya Ako,

Masao Yamasaki,

Tomomi Koizumi,

Ryota Sakurai,

Yoichiro Hongo,

BonKwon Koo,

John A. Ormiston,

Stephen G. Worthley,

Robert Whitbourn,

D. Walters,

Ian T. Meredith,

Peter J. Fitzgerald,

Yasuhiro Honda

Publication year - 2011

Publication title -

circulation cardiovascular interventions

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.621

H-Index - 95

eISSN - 1941-7632

pISSN - 1941-7640

DOI - 10.1161/circinterventions.110.957548

Subject(s) - neointima , stent , intravascular ultrasound , medicine , lumen (anatomy) , artery , drug eluting stent , radiology , cardiology , surgery , restenosis

Polymer formulation may affect the efficacy of drug-eluting stents. Resolute, Endeavor, and ZoMaxx are zotarolimus-eluting stents with different stent platforms and different polymer coatings and have been tested in clinical trials. The aim of this analysis was to compare the efficacy of zotarolimus-eluting stents with different polymers.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research